2A3S6-IMI500Patient Monitor

Infinium Medical, Inc

Application Details

Equipment Class: DTS - Digital Transmission System
Date of Grant: Sep 10, 2024
Application Purpose: Original Equipment
Date of Application: Sep 10, 2024
Equipment Note: Patient Monitor
Frequency Range: 2412.00000000 - 2462.00000000
Company: Infinium Medical, Inc
Country: United States

Documents & Files

Select a file to view

Document Text

Text extracted from the exhibit documents filed with the FCC. Open a document above to read the original.

Attestation Statements

Rev1/26/2023 InfiniumMedical,Inc FederalCommunicationsCommission AuthorizationandEvaluationDivision 7435OaklandMillsRoad Columbia,MD21046 USA Companyname:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ProductName:PatientMonitor FCCID:2A3S6-IMI500 Model(s):AlphaPM22 Ref:AttestationStatementsPart2.911(d)(5)(i)Filing We,[InfiniumMedicalInc.](“theapplicant”)certifiesthattheequipmentforwhich authorizationissoughtisnot“covered”equipmentprohibitedfromreceivinganequipment authorizationpursuanttosection2.903oftheFCCrules. YoursSincerely, Name:NickWilkinsDate:2024.08.02 Title:DirectorofQualityAssuranceandRegulatoryAffairs Signatureofapplicant:

Attestation Statements

Rev1/26/2023 InfiniumMedical,Inc FederalCommunicationsCommission AuthorizationandEvaluationDivision 7435OaklandMillsRoad Columbia,MD21046 USA Date:2024.08.026 Ref:AttestationStatementsPart2.911(d)(7)Filing We,[InfiniumMedical,Inc](“theapplicant”)certifiesthat,asofthedateofthefilingofthe application,designateourselfasU.S.agentforserviceofprocess. DesignatedU.S.AgentInformation: Name:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ContactPerson:NickWilkins Tel.:1-886-918-8434 Email:[email protected] FRN:0003766102 FCCID：2A3S6-IMI500 Sincerely, Applicantsignature: Applicantprintedname:NickWilkins CompanyName:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates Email:[email protected]

Cover Letter(s)

InfiniumMedical,Inc OfficeofEngineeringTechnology FederalCommunicationsCommission 7435OaklandMillsRoad Columbia,MD21046 Date:2024.08.26 Subject;RequestforConfidentiality FCCID:2A3S6-IMI500 ToWhomItMayConcern, PursuanttotheprovisionsoftheCommission’srulesTitle47Sections§0.457and§0.459,weare requestingtheCommissiontowithholdthefollowingattachment(s)asconfidentialdocumentsfrom publicdisclosureindefinitely. Thesedocumentscontaindetailedsystemandequipmentdescriptionsandareconsideredasproprietary informationinoperationoftheequipment.Thepublicdisclosureofthesedocumentsmightbeharmfulto ourcompanyandwouldgivecompetitorsanunfairadvantageinthemarket. SchematicDiagram BlockDiagram OperationalDescription Inadditionaltoabovementioneddocuments,inordertocomplywiththemarketingregulationsinTitle 47CFR§2.803andtheimportationrulesinTitle47CFR§2.1204,whileensuringthatbusinesssensitive informationremainsconfidentialuntiltheactualmarketingofnewlyauthorizeddevices,werequestShort TermConfidentialityofthefollowingattachment(s); ExternalPhotos TestSetupPhotos InternalPhotos UserManual For45days,pursuanttoPublicNoticeDA04-1705. OR For180dayspursuanttoKDB726920D01. Itisourunderstandingthatallmeasurementtestreports,FCCIDlabelformatandcorrespondenceduring thecertificationreviewprocesscannotbegrantedasconfidentialdocumentsandthisinformationwillbe availableforpublicreviewoncethegrantofequipmentauthorizationisissued. Sincerely, Signature: Name:NickWilkins

Cover Letter(s)

LetterofAuthorization Company:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ProductName:PatientMonitor ModelNumber:AlphaPM22 FCCID:2A3S6-IMI500 WeauthorizeMiCOMLabsInc,575BoulderCourt,Pleasanton,California94566,USA, toactonourbehalfonallmattersconcerningtheabovenamedequipment. AnyindividualwithinMiCOMLabsisauthorizedtoactonourbehalfandtakeactionon theapplication. WedeclarethatMiCOMLabsInc,575BoulderCourt,Pleasanton,California94566, USA,isallowedtoforwardallinformationrelatedtotheapprovalprojecttotheFederal CommunicationCommissionandtodiscussanyissuesconcerningtheapproval application.AnyandallactscarriedoutbyMiCOMLabsonourbehalfshallhavethe sameeffectasactsofourown. Name:NickWilkinsDate:2024.08.02 Title:DirectorofQualityAssuranceandRegulatoryAffairs Signatureofapplicant:

RF Exposure Info

ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page1of8 RFMPEREPORT ReportNo.:20240517G07861X-W3 ProductName:PatientMonitor ModelNo.:AlphaPM22 FCCID:2A3S6-IMI500 Applicant:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates DatesofTesting:05/13/2024-06/14/2024 Issuedby:CCICSouthernTestingCo.,Ltd. LabLocation: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet, NanshanDistrict,Shenzhen,Guangdong,China. Tel：8675526627338E-Mail：[email protected] Thistestreportconsistsof8pagesintotal.Itmaybeduplicatedcompletelyforlegalusewith theapprovaloftheapplicant.Itshouldnotbereproducedexceptinfull,withoutthewritten approvalofourlaboratory.Theclientshouldnotuseittoclaimproductendorsementby CCIC-SET.Thetestresultsinthereportonlyapplytothetestedsample.Thetestreportshall beinvalidwithoutallthesignaturesoftestingengineers,reviewerandapprover.Any objectionsmustberaisedtoCCIC-SETwithin15dayssincethedatewhenthereportis received.Itwillnotbetakenintoconsiderationbeyondthislimit. ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page2of8 TestReport Product......................................:PatientMonitor BrandName ............................. : TradeName............................: Applicant...................................:InfiniumMedical,Inc ApplicantAddress .................. :1215162ndSt.N.#5LargoFlorida,33773,UnitedStates Manufacturer ............................ :InfiniumMedical,Inc ManufacturerAddress...........:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates TestStandards........................:47CFRPart2.1091 TestResult ................................ : Pass[ 盖章 ] Testedby.................................: 2024.06.28 KimLi,TestEngineer Reviewedby.............................: 2024.06.28 SunJiaohui,SeniorEngineer Approvedby............................: 2024.06.28 ChrisYou,Manager ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page3of8 TableofContents 1.GENERALINFORMATION....................................................................................................5 1.1.EUTDescription.......................................................................................................................5 1.2.EUTDescription.......................................................................................................................6 1.3.LaboratoryFacilities.................................................................................................................6 1.4.LaboratoryLocation.................................................................................................................6 2.TECHNICALREQUIREMENTSSPECIFICATIONINCFRTITLE47PART2.1091...7 2.1.ExposureLimits........................................................................................................................7 2.2.PredicationofMPElimitatagivendistance...........................................................................7 2.3.EvaluationResults....................................................................................................................8 2.4.Conclusion................................................................................................................................8 ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page4of8 ChangeHistory IssueDateReasonforchange 1.02024.06.28Firstedition ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page5of8 1.GENERALINFORMATION 1.1.EUTDescription ProductNamePatientMonitor EUTsupportsRadiosapplication2.4GWIFI FrequencyRange(Tx) 2.4GWIFI:2.412GHz~2.462GHz Bandwidth 802.11b/g/n-HT20:20MHz 802.11n-HT40:40MHz ModulationType2.4GWIFI:DSSS(802.11b),OFDM(802.11g/n) Antennagain2.4GWIFI:3.0dBi AntennaTypeInternalAntenna Note1:Theinformationofantennagainandcablelossisprovidedbythemanufacturerandourlabis notresponsiblefortheaccuracyoftheantennagainandcablelossinformation. ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page6of8 1.2.EUTDescription EUThasbeentestedaccordingtothefollowingstandards. No.IdentityDocumentTitle 147CFRPart1PracticeandProcedure 247CFRPart2 FrequencyAllocationsandRadioTreatyMatters;General RulesandRegulations 3 KDB447498D01General RFExposureGuidancev06 RFExposureProceduresandEquipmentAuthorization PoliciesforMobileandPortableDevices 4 OETBulletin65 Edition97-01 EvaluatingCompliancewithFCCGuidelinesforHuman ExposuretoRadiofrequencyElectromagneticFields 1.3.LaboratoryFacilities FCC-RegistrationNo.:CN1283 CCICSouthernTestingCo.,LtdEMCLaboratoryhasbeenregisteredandfullydescribedinareport filedwiththeFCC(FederalCommunicationsCommission).TheacceptanceletterfromtheFCCis maintainedinourfiles.DesignationNumber:CN1283,validtimeisuntilJun.30th,2025. ISEDRegistration:11185A-1 CCICSouthernTestingCo.,Ltd.EMCLaboratoryhasbeenregisteredbyCertificationand EngineeringBureauofIndustryCanadafortheperformanceofradiatedmeasurementswith RegistrationNo.11185AonAug.04,2016,validtimeisuntilJun.30th,2025. CABnumber:CN0064 A2LACode:5721.01 CCIC-SETisathirdpartytestingorganizationaccreditedbyA2LAaccordingtoISO/IEC17025. Theaccreditationcertificatenumberis5721.01. 1.4.LaboratoryLocation CompanyName:CCICSouthernTestingCo.,Ltd. Address: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet,Nanshan District,Shenzhen,Guangdong,China ReportNo.:20240517G07861X-W3 CCIC-SET/TRF:IRF(2024-04-29)Page7of8 2.TechnicalRequirementsSpecificationinCFRTitle47Part2.1091 2.1.ExposureLimits Thecriterialistedinthefollowingtableshallbeusedtoevaluatetheenvironmentimpactofhuman exposuretoradiofrequency(RF)radiationasspecifiedin1.1307(b). Table1to§1.1310(e)(1)-LimitsforMaximumPermissibleExposure(MPE) FrequencyRange (MHz) ElectricField Strength (V/m) MagneticField Strength (A/m) PowerDensity (mW/cm2) AveragingTime (minutes) (i)LimitsforOccupational/ControlledExposure 0.3-3.06141.63*(100)<6 3.0-301824/f4.89/f*(900/f 2 )<6 30-30061.40.1631.0<6 300-1500//f/300<6 1500-100,000//5<6 (ii)LimitsforGeneralPopulation/UncontrolledExposure 0.3-1.346141.63*(100)<30 1.34-30824/f2.19/f*(180/f 2 )<30 30…

Text truncated - open the document above for the full version.

Test Report

ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page1of61 RFTESTREPORT ReportNo.:20240517G07861X-W2 ProductName:PatientMonitor ModelNo.:AlphaPM22 FCCID:2A3S6-IMI500 Applicant:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates DatesofTesting:05/13/2024-06/14/2024 Issuedby:CCICSouthernTestingCo.,Ltd. LabLocation: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet, NanshanDistrict,Shenzhen,Guangdong,China. Tel：8675526627338E-Mail：[email protected] Thistestreportconsistsof61pagesintotal.Itmaybeduplicatedcompletelyforlegaluse withtheapprovaloftheapplicant.Itshouldnotbereproducedexceptinfull,withoutthe writtenapprovalofourlaboratory.Theclientshouldnotuseittoclaimproductendorsement byCCIC-SET.Thetestresultsinthereportonlyapplytothetestedsample.Thetestreport shallbeinvalidwithoutallthesignaturesoftestingengineers,reviewerandapprover.Any objectionsmustberaisedtoCCIC-SETwithin15dayssincethedatewhenthereportis received.Itwillnotbetakenintoconsiderationbeyondthislimit. ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page2of61 TestReport Product......................................:PatientMonitor BrandName ............................. : TradeName............................: Applicant...................................:InfiniumMedical,Inc ApplicantAddress .................. :1215162ndSt.N.#5LargoFlorida,33773,UnitedStates Manufacturer ............................ :InfiniumMedical,Inc ManufacturerAddress...........:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates TestStandards........................: 47CFRPart15SubpartC ANSIC63.10-2020 TestResult ................................ : Pass[ 盖章 ] Testedby.................................: 2024.06.28 KimLi,TestEngineer Reviewedby ............................. : 2024.06.28 SunJiaohui,SeniorEngineer Approvedby............................: 2024.06.28 ChrisYou,Manager ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page3of61 TABLEOFCONTENTS 1.GENERALINFORMATION....................................................................................................5 1.1.EUTDescription.......................................................................................................................5 1.2.TestStandardsandResults.......................................................................................................6 1.3.ChannelList..............................................................................................................................6 1.4.Testenvironmentandmode......................................................................................................7 1.5.TableforSupportingUnits.......................................................................................................7 1.6.EUTOperationTestSetup........................................................................................................7 1.7.LaboratoryFacilities.................................................................................................................8 2.TESTREQUIREMENTS..........................................................................................................9 2.1.Antennarequirement................................................................................................................9 2.2.MaximumConductedOutputPower......................................................................................10 2.3.6dBand99%Bandwidth........................................................................................................12 2.4.Powerspectraldensity(PSD).................................................................................................14 2.5.ConductedBandEdgesandSpuriousEmissions...................................................................16 2.6.RadiatedBandEdgeandSpuriousEmission..........................................................................18 2.7.ACPowerLineConductedEmission.....................................................................................32 3.LISTOFMEASURINGEQUIPMENT.................................................................................36 4.UNCERTAINTYOFEVALUATION.....................................................................................37 APPENDIXA..................................................................................................................................38 ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page4of61 ChangeHistory IssueDateReasonforchange 1.02024.06.28Firstedition ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page5of61 1.GENERALINFORMATION 1.1.EUTDescription ProductNamePatientMonitor EUTsupportsRadios application WLAN2.4GHz802.11b/g/n(HT20/HT40) FrequencyRange 802.11b/g/n-20MHz:2.412GHz~2.462GHz 802.11n-40MHz:2.422GHz-2.452GHz ChannelNumber 802.11b/g/n-20MHz:11 802.11n-40MHz:7 TransferRate 802.11b:11/5.5/2/1Mbps 802.11g:54/48/36/24/18/12/9/6Mbps 802.11n:upto150Mbps ModulationTypeDSSS(802.11b),OFDM(802.11g/n) AntennaTypeInternalAntenna AntennaGain3.0dBi PowersupplyRechargeableLi-ionBatteryDC11.1V/5200mAh Note1:Foramoredetaileddescription,pleaserefertoSpecificationorUser’sManualsuppliedby theapplicantand/ormanufacturer. Note2:TheEUTwasprogrammedtobeincontinuouslytransmittingmodeandthetransmitduty cycleisnotlessthan98%. Note3:Theinformationofantennagainandcablelossisprovidedbythemanufacturerandourlabis notresponsiblefortheaccuracyoftheantennagainandcablelossinformation. ReportNo.:20240517G07861X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page6of61 1.2.TestStandardsandResults ThepurposeofthereportistoconducttestingaccordingtothefollowingFCCcertification standards: No.IdentityDocumentTitle 1 47CFRPart15 SubpartC RadioFrequencyDevices 2 KDB558074D01 15.247MeasGuidance v05r02 CuidanceforComplianceMeasurementonDigital TransmissionSystems,FrequencyHoppingSpreadSpectrum Systems,andHybridSystemDevicesOperatingunderSection 15.247oftheFCCRules 4ANSIC63.10-2020 AmericanNationalStandardforTestingUnlicensedWireless Devices Testdetaile…

Text truncated - open the document above for the full version.

Test Report

add：东莞市长厦岗夏联路1号Tel:0769-89158063 Fax:0769-85309196 承认书项目表 ---10 --- 12 ---11 9 8 7 61增益测试（Gain Test ）6 51S参数测试（S Parameter ）5 41电性测试报告（Test Reports ）4 31工程成品图（Drawing）3 21承认书项目表（Spec Item ）2 11承认书封面（Spec Cover）1 页码（Page Code）页数（Number of Page）内容（Contents） NO. add：东莞市长厦岗夏联路1号Tel:0769-89158063 Fax:0769-85309196 BlackCable Color -40 ~ +85 ̊CStorage Temp. -40 ~ +85 ̊COperating Temp. O.D. 1.13mm // 220 mmCable Type FPCBAntenna Material Physical Properties ipexConnector 1 WAdmitted Power Linear, VerticalPolarization 3.2 dB / m Max @ 2450 MHzCable Loss 3dBiGain (Peak) Omni-directionalRadiation -10 dB MaxReturn Loss 1.92 : 1 MaxV.S.W.R 50 0hm Nominal Impedance 2.4GHzFrequency Electrical Properties 电性测试报告 Test Reports add：东莞市长厦岗厦联路Tel:0769-89158063 Fax:0769-85309196 S 参数测试 S Parameter Test Agilent E5071C add：东莞市长厦岗夏联路1号Tel:0769-89158063 Fax:0769-85309196 增益测试 Gain Test Antenna Radiation Pattern VS Gain 0 45 90 135 180 225 270 315 -5 -5 -15 -15 -25 -25 -35 -35 -45

Contact Information

Applicant

Nicholas Wilkins(Director of QA/RA)

[email protected]6143780036Fax: 8669188434

Technical Contact

lnfinium Medical, lnc

[email protected]

United States

Test Firm

CCIC Southern Testing Co., LtdChris You

[email protected]86-0755-86131239

Technical Specifications

#	Rule Parts	Frequency Range	Power Output
1	15C	2.41 GHz - 2.46 GHz	44.00 mW

Confidentiality

Long Term

Grant Notes

Power listed is the maximum conducted output power. This device contains 20 and 40 MHz signal bandwidth. The antenna used for this transmitter must be installed to provide a separation distance of at least 20 cm from all persons and must not be co-located or operating in conjunction with any other antenna or transmitter, except in accordance with FCC multi- transmitter product procedures. End-Users must be provided with transmitter operation conditions for satisfying RF exposure compliance.